GLP-1 & High Cost Drug Strategy

$0.00

Control high-cost drug spend without restricting access

  • Design coverage strategies for high-cost therapies

  • Build step therapy and prior authorization frameworks

  • Align access with formulary and rebate strategy

  • Identify opportunities for biosimilars and alternatives

  • Balance clinical outcomes with financial sustainability

Control high-cost drug spend without restricting access

  • Design coverage strategies for high-cost therapies

  • Build step therapy and prior authorization frameworks

  • Align access with formulary and rebate strategy

  • Identify opportunities for biosimilars and alternatives

  • Balance clinical outcomes with financial sustainability